Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Peringkat dalam Saham #14517
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Harga Saham
$0.87120957
Kapitalisasi Pasar
$405.07M
Perubahan (1 hari)
-0.64%
Perubahan (1 tahun)
57.03%
Negara
SE
Perdagangan Egetis Therapeutics AB (publ) (EGTX)

Kategori

Riwayat harga saham Egetis Therapeutics AB (publ) (EGTX)
Harga penutupan tertinggi: $0.87 pada 2026-09-01

Harga penutupan terendah: $2.05 pada 2011-04-01
Riwayat harga saham Egetis Therapeutics AB (publ) dari 2011 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 16.99%
2025 -9.69%
2024 12.61%
2023 5.26%
2022 -32.21%
2021 -1.08%
2020 -64.01%
2019 24.17%
2018 -26.69%
2017 31.53%
2016 -66.48%
2015 78.45%
2014 56.36%
2013 68.37%
2012 3.47%
2011 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$749.64 5.07%
CH